Acyclovir
- Product NDC
- 70934-401
- 11-digit product format
- 709340401
- Labeler code
- 70934
- Product ID
- 70934-401_af48278e-a970-fe13-e053-2a95a90adf27
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- Acyclovir
- Dosage form
- TABLET
- Route
- ORAL
- Labeler
- Denton Pharma, Inc. DBA Northwind Pharmaceuticals
- Application
- ANDA210401
- Marketing category
- ANDA
- Marketing start
- 2019-06-25
- Marketing end
- 0000-00-00
- Substance
- ACYCLOVIR
- Active strength
- 800 mg/1
- Pharmacologic classes
- DNA Polymerase Inhibitors [MoA],Herpes Simplex Virus Nucleoside Analog DNA Polymerase Inhibitor [EPC],Herpes Zoster Virus Nucleoside Analog DNA Polymerase Inhibitor [EPC],Herpesvirus Nucleoside Analog DNA Polymerase Inhibitor [EPC],Nucleoside Analog [EXT]
- NDC exclude flag
- No
- Listing certified through
- 2021-12-31
- Current FDA listing
- Historical FDA.report record
Packages#
| Package NDC | 11-digit format | Description | Units | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|---|---|---|---|---|---|---|---|
| 70934-401-35 | 70934040135 | 35 TABLET in 1 BOTTLE, PLASTIC (70934-401-35) | 35 tablet | 2019-06-25 | 0000-00-00 | No | No | Current |
| 70934-401-40 | 70934040140 | 40 TABLET in 1 BOTTLE, PLASTIC (70934-401-40) | 40 tablet | 2019-08-19 | 0000-00-00 | No | No | Current |